How Will the Bipolar Disorder Therapeutics Market Grow? Key Trends and Opportunities for 2025 and Beyond
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What fueled the previous growth in the bipolar disorder therapeutics market?
The market size for therapeutics in bipolar disorder has seen robust growth in the past few years. Projected growth shows an increase from $7.44 billion in 2024 to $7.89 billion in 2025, with a compound annual growth rate (CAGR) of 6.0%. Factors contributing to this growth during the historic period include advances in medical research and developments, augmented healthcare spending, an increase in the incidence of mental health disorders, and increased patient advocacy.
What will be the bipolar disorder therapeutics market size in the future?
The market size for bipolar disorder treatments is projected to witness substantial expansion in the upcoming years. It is anticipated to achieve a value of $9.98 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.1%. The predicted growth within this period is due to factors such as the rising occurrence of bipolar disorder, government efforts, advancements in the healthcare structure, and an increasing trend of sedentary lifestyle. The forecast period also shows significant trends including individualized treatment strategies, incorporation of digital health, novel medications, proactive interventions, and the use of neuroimaging and biomarkers.
Get your bipolar disorder therapeutics market report here!
https://www.thebusinessresearchcompany.com/report/bipolar-disorder-therapeutics-global-market-report
What main drivers are fueling expansion in the bipolar disorder therapeutics market?
The market size for bipolar disorder treatments is projected to witness substantial expansion in the upcoming years. It is anticipated to achieve a value of $9.98 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.1%. The predicted growth within this period is due to factors such as the rising occurrence of bipolar disorder, government efforts, advancements in the healthcare structure, and an increasing trend of sedentary lifestyle. The forecast period also shows significant trends including individualized treatment strategies, incorporation of digital health, novel medications, proactive interventions, and the use of neuroimaging and biomarkers.
What key areas define the segmentation of the global bipolar disorder therapeutics market?
The bipolar disorder therapeutics market covered in this report is segmented – _x000D_
_x000D_
1) By Drug Class: Mood Stabilizers, Antipsychotic Drugs, Antidepressant Drugs, Other Drugs_x000D_
2) By Mechanism: Selective Serotonin Reuptake Inhibitors, Serotonin-norepinephrine Reuptake Inhibitors, Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, Benzodiazepines, Beta-Blockers, Other Mechanisms_x000D_
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies_x000D_
_x000D_
Subsegments:_x000D_
1) By Mood Stabilizers: Lithium, Anticonvulsants, Calcium Channel Blockers _x000D_
2) By Antipsychotic Drugs: Atypical Antipsychotics, Typical Antipsychotics _x000D_
3) By Antidepressant Drugs: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Tricyclic Antidepressants (TCAs) _x000D_
4) By Other Drugs: Benzodiazepines, Adjunctive Therapies, Herbal Supplements
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6736&type=smp
Who are the dominant players expanding their reach in the bipolar disorder therapeutics market?
Major companies operating in the bipolar disorder therapeutics market include AbbVie Inc., Pfizer Inc., Astellas Pharma Inc, AstraZeneca PLC, Bristol-Myers Squibb, GlaxoSmithKline PLC, Januaryssen Pharmaceuticals, Novartis AG, Otsuka Pharmaceutical Co. Ltd., Validus Pharmaceuticals, Eli Lilly and Company, Gedeon Richter PLC., Sumitomo Pharma Co. Ltd, H. Lundbeck A/S, Janssen Pharmaceuticals, Sanofi S.A., Lundbeck A/S, Allergan plc, Takeda Pharmaceutical Company Limited, Sunovion Pharmaceuticals Inc., Alkermes plc, Mylan N.V., Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Celon Pharma SA, NeuroRx Inc., IntraCellular Therapies Inc., Sumitomo Pharma Co. Ltd., Vanda Pharmaceuticals Inc., Sage Therapeutics Inc.
How are evolving market trends shaping bipolar disorder therapeutics Strategies?
Establishing strategic alliances is a prominent trend gaining traction in the bipolar disorder therapeutics market. Firms within this sector are increasingly focusing on forming partnerships to solidify their market standing. For example, in April 2022, BioXcel Therapeutics, Inc., a biopharmaceutical organization based in the US, granted approval for IGALMITM (dexmedetomidine), a sublingual film devised for the immediate treatment of agitation linked with schizophrenia or bipolar I or II disorder in adults, and it is specifically FDA-approved. This film dissolves in the mouth and is specifically aimed at dealing with various levels of agitation, from mild to severe, in these patient demographics. The medication is engineered for quick response, thereby allowing effective control of agitation incidents.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6736
Which regions are emerging as leaders in the bipolar disorder therapeutics market?
North America was the largest region in the bipolar disorder therapeutics market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the bipolar disorder therapeutics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Healthcare Nanotechnology Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/healthcare-nanotechnology-global-market-report
Healthcare Personal Protective Equipment Global Market Report 2024
Healthcare RFID Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/healthcare-rfid-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
